Teladoc Health (NYSE:TDOC – Get Free Report) and OptimizeRx (NASDAQ:OPRX – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.
Profitability
This table compares Teladoc Health and OptimizeRx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Teladoc Health | -6.27% | -11.63% | -5.53% |
| OptimizeRx | 5.33% | 9.58% | 7.47% |
Analyst Ratings
This is a summary of recent ratings for Teladoc Health and OptimizeRx, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Teladoc Health | 2 | 11 | 5 | 0 | 2.17 |
| OptimizeRx | 1 | 2 | 6 | 0 | 2.56 |
Teladoc Health currently has a consensus target price of $8.53, indicating a potential downside of 2.14%. OptimizeRx has a consensus target price of $11.21, indicating a potential upside of 54.70%. Given OptimizeRx’s stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than Teladoc Health.
Valuation and Earnings
This table compares Teladoc Health and OptimizeRx”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Teladoc Health | $2.47 billion | 0.64 | -$200.32 million | ($0.86) | -10.14 |
| OptimizeRx | $109.43 million | 1.25 | $5.13 million | $0.25 | 29.00 |
OptimizeRx has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 0.7% of Teladoc Health shares are held by company insiders. Comparatively, 7.5% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
Teladoc Health has a beta of 2, meaning that its stock price is 100% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500.
Summary
OptimizeRx beats Teladoc Health on 11 of the 14 factors compared between the two stocks.
About Teladoc Health
Teladoc Health, Inc. provides virtual healthcare services through a digital platform that connects individuals with clinicians and other health professionals. Its offerings include virtual primary and specialty care, mental health services, and support for managing chronic conditions. The company serves members in the United States and internationally, with services and availability varying by market. Its consumer mental health services include BetterHelp, while its chronic-care programs draw on technology and services developed by Livongo, which Teladoc acquired in 2020.
About OptimizeRx
OptimizeRx is a healthcare technology company that connects life sciences companies with healthcare professionals and patients through digital communications. Its platform uses channels such as electronic health records and other clinical workflows to deliver relevant information at the point of care. The company’s services support programs for medication access and affordability, patient education and engagement, and communication between healthcare providers and life sciences organizations. OptimizeRx also provides tools intended to help life sciences companies reach clinicians and patients through digital channels.
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
